aecom selected as designers to support major capital project delivery for southern water
DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced it has been selected by two contractors to...
Month: October 2024
rail vision announces $20 million standby equity purchase agreement
Securing this strategic financial partnership will support Rail Vision’s expected market expansion, growth initiatives and financial requirements Ra’anana, Israel, Oct....
prelude therapeutics announces publication of abstracts for presentation at the 36th eortc-nci-aacr symposium
WILMINGTON, Del., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD) (“Prelude” or the “Company”), a clinical-stage precision...
dyne therapeutics presents data at world muscle society congress highlighting promise of force™ platform to address underlying causes of neuromuscular diseases
- Presentations Will Feature Recent Clinical Data From DYNE-251 and DYNE-101 as Well as Preclinical Data in FSHD and Pompe...
oragenics, inc. updates shareholders on concussion drug progress and phase ii trial preparation
SARASOTA, Fla., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a biopharmaceutical company committed to developing novel...
canopy growth confirms canopy usa’s acquisition of wana
Canopy USA is fulfilling its ambition of establishing a leading brand-focused cannabis company concentrated on state-legal markets and hemp-derived products...
biogen receives u.s. fda breakthrough therapy designation for felzartamab for the treatment of antibody-mediated rejection in kidney transplant recipients
Designation is based on data from the clinical development program which demonstrated clinical proof of conceptFelzartamab, an investigational anti-CD38 monoclonal...
unicycive therapeutics successfully completes uni-494 phase 1 study in healthy volunteers
LOS ALTOS, Calif., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for...
tc energy announces upsizing and results of its cash tender offers
CALGARY, Alberta, Oct. 09, 2024 (GLOBE NEWSWIRE) -- News Release – TC Energy Corporation (TSX, NYSE: TRP) (“TC Energy”) today...
tc energy announces expiration and upsizing of cash tender offers for certain canadian-dollar denominated debt securities
NOT FOR DISTRIBUTION IN THE UNITED STATES OR TO U.S. NEWSWIRE SERVICES (SEE “OFFER AND DISTRIBUTION RESTRICTIONS” BELOW). CALGARY, Alberta,...
theratechnologies to present data at idweek 2024 highlighting advances in treatment and management of complications in people with hiv
MONTREAL, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company...
promising results from drilling at seabridge gold’s iskut project
Hole 17 intersects 303m of 0.75 gpt gold and 0.10% copperHole 18 intersects 478m of 0.49 gpt gold and 0.13%...
metals acquisition limited raises ~a$150 million (~us$103 million) through successful placement
ST. HELIER, Jersey--(BUSINESS WIRE)--Metals Acquisition Limited (NYSE: MTAL; ASX:MAC) Highlights MAC has received firm commitments to raise approximately A$150 million...
viking therapeutics announces results from phase 1b clinical trial of vk0214 in patients with x-ald
Reductions in Very Long-Chain Fatty Acids and Plasma Lipid Levels Observed After 28 Days of Once Daily Dosing VK0214 Shown...
americas gold and silver to consolidate the galena complex in transaction with eric sprott;paul andre huet to be appointed chairman and chief executive officer
/FOR DISTRIBUTION IN THE UNITED STATES/ TORONTO, Oct. 9, 2024 /PRNewswire/ - Americas Gold and Silver Corporation (TSX: USA) (NYSE...
kymera therapeutics announces fda clearance of investigational new drug application for kt-621, a first-in-class, oral stat6 degrader
KT-621 has demonstrated dupilumab-like activity and was well tolerated ina wide variety of preclinical models of TH2 diseases KT-621 is...
entrada therapeutics presents new data supporting its expanding duchenne franchise at the 29th annual congress of the world muscle society
– Additional positive data from the Company’s completed Phase 1 clinical trial evaluating ENTR-601-44 reinforces its safety profile and supports...
stallion uranium signs binding loi for up to $2.2m for horse heaven gold and antimony project
VANCOUVER, British Columbia, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Stallion Uranium Corp. (the "Company" or "Stallion") (TSX-V: STUD; OTCQB: STLNF;...
aecom selected as designers to support major capital project delivery for southern water
DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced it has been selected by two contractors to...
aecom selected as designers to support major capital project delivery for southern water
DALLAS--(BUSINESS WIRE)--AECOM (NYSE: ACM), the world’s trusted infrastructure consulting firm, today announced it has been selected by two contractors to...
helen of troy limited reports second quarter fiscal 2025 results
EL PASO, Texas--(BUSINESS WIRE)--Helen of Troy Limited (NASDAQ: HELE), designer, developer, and worldwide marketer of branded consumer home, outdoor, beauty,...
new prospective, multicenter study presented at smr demonstrates castle biosciences’ decisiondx®-melanoma test provides significant risk prediction for patients with cutaneous melanoma, adding value to current stage-based treatment pathway decisions
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced...
novavax’s updated 2024-2025 nuvaxovid™ covid-19 vaccine receives authorization in the eu
GAITHERSBURG, Md., Oct. 9, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™...
nurix therapeutics announces presentations at acr convergence 2024, the annual meeting of the american college of rheumatology
SAN FRANCISCO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical stage biopharmaceutical company developing targeted...
caredx appoints jing huang chief data and ai officer
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA)- The Transplant Company™ — a leading precision medicine company focused on the discovery, development,...
sonendo executes asset purchase agreement to acquire biolase assets
LAGUNA HILLS, Calif.--(BUSINESS WIRE)--Sonendo, Inc. (OTCQX: SONX) (“Sonendo” or “Company”), a leading dental technology company and developer of the GentleWave®...
viatris announces positive top-line results from phase 3 study of effexor® in japanese adults with generalized anxiety disorder (gad)
Treatment with once-daily EFFEXOR® met primary and all secondary efficacy endpoints in outpatient adults with GAD EFFEXOR® was generally well...
viasat to enhance business aviation in-flight connectivity with uncapped speeds, expanded capacity and increased network prioritization
Jet ConneX customers will be the first to benefit from the ground-breaking JetXP enhancement program, which delivers a truly seamless...
ocugen, inc. announces removal of clinical hold on investigational new drug application for ocu200 phase 1 clinical trial
MALVERN, Pa., Oct. 09, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a biotechnology company focused...
clearside biomedical announces positive topline results from odyssey phase 2b trial of suprachoroidal cls-ax in wet amd achieving all primary and secondary outcomes
- Maintained Stable Visual Acuity and Anatomical Control Over 9 Months - - Positive Safety Profile with No Ocular or...
24/7 Market News Snapshot 09 October, 2024 – Clearside Biomedical, Inc. Common Stock (NASDAQ:CLSD)
DENVER, Colo., 09 October, 2024 (247marketnews.com) – (NASDAQ:CLSD) are discussed in this article. Clearside Biomedical, Inc. is currently experiencing significant...
hercules capital receives reaffirmed baa3 investment grade rating with revised outlook to positive from moody’s investors service
SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) (“Hercules” or the “Company”), the largest and leading specialty financing provider to...
2024 global research: wealth management market projected to expand significantly by 2028, driven by technological innovation and hni trends
Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Global Wealth Management Market 2024-2028" report has been added to ResearchAndMarkets.com's offeringThe...
vertex energy announces successful startup of mobile refinery hydrocracker in conventional service
HOUSTON--(BUSINESS WIRE)--Vertex Energy, Inc. (OTCPK:VTNRQ) ("Vertex" or the "Company"), a leading specialty refiner and marketer of high-quality refined products, today...
argyle resources provides update on matapedia silica project developments and upcoming exploration plans
Calgary, Alberta--(Newsfile Corp. - October 9, 2024) - Argyle Resources Corp. (CSE: ARGL) (OTCQB: ARLYF) (FSE: ME0) ("Argyle" or the...
global net lease completes $569 million of dispositions through third quarter of 2024
NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- Global Net Lease, Inc. (NYSE: GNL) (“GNL” or the “Company”) today announced...
cleveland-cliffs receives canadian competition bureau clearance for the acquisition of stelco
CLEVELAND--(BUSINESS WIRE)--Cleveland-Cliffs Inc. (NYSE: CLF) (“Cliffs”) today announced that it has received a "no-action letter" from the Canadian Competition Bureau...
verastem oncology announces details for the oral presentation of the mature ramp 201 data evaluating avutometinib plus defactinib in recurrent low-grade serous ovarian cancer at the igcs 2024 annual meeting
BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced further...
delek logistics partners, lp announces pricing of public offering of common units
BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek Logistics Partners, LP (NYSE: DKL) (“Delek Logistics”) announced today the pricing of its underwritten public offering of...
newmont announces definitive agreement to divest akyem for up to $1 billion
DENVER--(BUSINESS WIRE)--Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) (“Newmont” or the “Company”) has announced today it will...